Who
Liane Rae Teplitsky
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Pulse Biosciences.
In numbers
- Trades disclosed
- 12
- Buys
- 4
- Sells
- 0
- Bought
- $400K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Aug 2026
- Last trade
- 1 Sep 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 2 Sep 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,001 at $49.95 | filing |
| 1 Sep 2026filed 2 Sep 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,001 at $49.95 | filing |
| 31 Aug 2026filed 2 Sep 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,024 at $48.80 | filing |
| 31 Aug 2026filed 2 Sep 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,024 at $48.80 | filing |
| 28 Aug 2026filed 28 Aug 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,034 at $48.35 | filing |
| 28 Aug 2026filed 28 Aug 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,034 at $48.35 | filing |
| 26 Aug 2026filed 28 Aug 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,036 at $48.24 | filing |
| 26 Aug 2026filed 28 Aug 2026 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Bought | $50K1,036 at $48.24 | filing |
| 8 Aug 2026filed 28 Aug 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 8 Aug 2026filed 28 Aug 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —700,000 at $0.00 | filing |
| 8 Aug 2026filed 28 Aug 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 8 Aug 2026filed 28 Aug 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —700,000 at $0.00 | filing |
News
Pulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule TreatmentPLSE · rttnews.com · 14 Oct 2026
0 headlines in the last 90 days name Liane Rae Teplitsky; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.